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ABS TRACT
Evolutionary science is indispensable for understanding biological processes. Effective medical treat-
ment must be anchored in sound biology. However, currently the insights available from evolutionary
science are not adequately incorporated in either pre-medical or medical school curricula. To illuminate
how evolution may be helpful in these areas, examples in which the insights of evolutionary science are
already improving medical treatment and ways in which evolutionary reasoning can be practiced in the
context of medicine are provided. To facilitate the learning of evolutionary principles, concepts derived
from evolutionary science that medical students and professionals should understand are outlined.
These concepts are designed to be authoritative and at the same time easily accessible for anyone with
the general biological knowledge of a first-year medical student. Thus, we conclude that medical practice
informed by evolutionary principles will be more effective and lead to better patient outcomes.
Furthermore, it is argued that evolutionary medicine complements general medical training because
it provides an additional means by which medical students can practice the critical thinking skills that
will be important in their future practice. We argue that core concepts from evolutionary science have
the potential to improve critical thinking and facilitate more effective learning in medical training.
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INTRODUCTION
Many leading scientific and medical bodies recog-
nize the growing importance of evolutionary science
to biology and medicine [1–3]. For example, for some
time now physicians have realized that intra-tumor
heterogeneity is a major factor in cancer treatment
failure [4–6]. Recent strides are being made to under-
stand this heterogeneity better by using methods
developed in evolutionary phylogenomics [6]. Of
course, the reason that this approach is essential
to understanding tumor dynamics is because as
tumors grow, they also evolve. As renegade cancer
cell lineages evolve, free from the controls of normal
cell division, clones expressing genetic elements
that increase their replication relative to others will
begin to dominate the tumor through the process of
natural selection. Furthermore, if drug therapy is
used to control the tumor growth, some clones will
evolve resistance to the particular drugs being ad-
ministered, with resistant clones reproducing at
greater rates than non-resistant clones. This is a
classic case of natural selection producing adapta-
tions to a novel compound, as seen in the case of
bacteria evolving resistance to antibiotics or HIV
evolving resistance to azidothymidine. This is just
one example of the many areas of medicine to which
evolutionary reasoning is increasingly critical (e.g.
atopic disease, senescence, genetic variation and
drug response) in diagnosis, treatment planning
and research.
Since the physicians of the future will be employ-
ing more applications of evolutionary science in
their practical work, it is crucial that we begin to en-
gage today’s medical students around these con-
cepts. Unfortunately, evolution education in US
lags behind that of other nations with advanced sci-
entific research programs, and misconceptions con-
cerning the core principles of evolutionary science
are widespread among the American public [7, 8].
Yet despite the importance of evolution to medicine,
the pre-medical curriculum and medical colleges
continue to offer sparse coverage of evolution.
One recent study surveyed curriculum deans of
North American medical schools allowing them to
rate their curriculum for coverage of 12 core con-
cepts in evolution. Of those surveyed, 60 schools
(39%) responded to the survey. The deans rated
three evolutionary principles as most important:
antibiotic resistance, environmental mismatch and
somatic selection in cancer. Despite this, coverage
of evolutionary principles lagged behind the
perceived importance of them by on average 21%
[9]. This study also compared its results to a previous
study [10] and found that the range of principles
covered had improved between 4 and 74%. The
Association of American Medical Colleges has
recognized the need for improving the education
of undergraduates in evolution [11]. Thus, the
Medical College Admission test now contains some
items that test prospective students’ comprehen-
sion of core evolutionary principles. This is a start,
but clearly a few items on an admission test are in-
sufficient to motivate a shift toward greater attention
to evolution in medical education.
Recognizing the growing number of physicians
and scientists focused on evolutionary science’s
promise for addressing health and disease as well
as the under-preparedness of medical students in
this area, in 2011 the National Science Foundation
(NSF)-supported National Evolutionary Synthesis
Center convened a working group to address the role
of evolutionary biology in medicine and medical edu-
cation. The group, led by physician Mark Schwartz
and evolutionary biologist Peter Ellison, consists of
physicians, researchers in the fields of evolutionary
medicine and public health and experts in evolution
education. The group’s advisory board included the
President of the Institute of Medicine and the Deans
of two prestigious medical schools (see Appendix A
for group members). In addition to recommending
that more attention be paid in the medical curricu-
lum to integrating core concepts of evolution into
appropriate courses and subject areas, the group
identified a set of crucial evolutionary concepts that
should be included in all medical curricula. These
concepts follow closely those recommended in pre-
vious analyses, and some examples of these con-
cepts are presented in Table 1 [12].
ESSENTIAL LEARNING OBJECTIVES
These evolutionary science concepts can be thought
of as a series of learning objectives, which, if mas-
tered by a student, entail a greater understanding of
both evolutionary reasoning and content knowledge
relevant to medical practice. Given the inadequate
training in evolutionary science that exists in our
present undergraduate education system [8] and
the depth to which evolutionary biology pervades
medical phenomena, memorizing the definitions
of important evolutionary science terms will not be
enough for modern medical students. This ap-
proach amounts to retrieving information from
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memory without necessarily being able to use the
knowledge in any way and represents the simplest
sort of learning (Level 1) according to Bloom’s
Revised Taxonomy [13]. This taxonomy is a widely
used tool in teaching, including in medical educa-
tion. For example, it has been recently used to meas-
ure cognitive processing and judgments of
knowledge in medical students, measuring the de-
sign and evaluation of assessment tools in the ana-
tomical sciences, the impact of flipped classrooms
in anatomy instruction and commitment to change
in clinical practice [14–17]. The popularity of this
method is that it allows assessment of student
learning that separates superficial from deep
learning [17]. It accomplishes this by providing care-
fully developed definitions of six major categories in
the cognitive domain: remembering, understand-
ing, applying, analysing, evaluating and creating.
Here, we propose that Bloom’s taxonomy may
also be employed to accomplish deep learning of
evolutionary principles for medical students. For ex-
ample, natural selection can be defined as differen-
tial survival or reproduction of individuals that result
in changes in the frequency of heritable traits in a
population. These individuals may represent differ-
ent genotypes leading to changes in allele
frequencies of the population. In some cases, the
individuals may represent different phenotypes
Table 1. Exemplars of evolutionary concepts, learning objectives and competencies relevant to medicine
Concept Learning objective Competency
Adaptation/adaptive Explain what is meant by adapta-
tion and how adaptations are
shaped by natural selection.
Students should be able to explain specific
examples of adaptation and how they may
impact specific diseases.
Examples in text: antimicrobial resist-
ance; sickle-cell anemia; skin color
variation
Hygiene hypothesis Explain the hygiene hypothesis. Students should be able to explain how the
hygiene hypothesis is applied to atopic
disease.
Example in text: allergy prevalence in
city v. country children
Life history theory (life history evolution) Explain how life histories evolve. Students should be able to explain how life
history theory accounts for aging.Example in text: senescence (aging)
Microbiome Describe the human microbiome. Students should be able to explain how vari-
ations in the human microbiome may be
associated with specific diseases.
Examples in text: bacteria/parasitic
worms and atopic disease;
microbiome and metabolic disease
Mismatch Explain evolutionary mismatch. Students should be able to explain how evo-
lutionary mismatches may contribute to
specific diseases.
Examples in text: novel (nano) mater-
ials; heart, cancer and metabolic dis-
ease pandemic in Western societies
Natural selection Define natural selection. Students should be able to explain how nat-
ural selection molds the characteristics of
a given species, including attributes of that
species relevant to disease.
Examples in text: intra-tumor hetero-
geneity; antimicrobial resistance;
sickle-cell anemia; skin color
variation
Race (biological and socially defined) Define biological and socially
defined race.
Students should be able to explain the differ-
ence between biological race categories
and socially defined categories. Specifically
students should understand the relevance
of this distinction to addressing health
disparities.
Examples in text: sickle-cell anemia;
olanzapine response variants; skin
color variation; pain tolerance myths
Trade-offs Define an evolutionary trade-off. Students should be able to explain why the
existence of trade-offs means that no bod-
ily system can be perfect.
Examples in text: senescence (aging);
intermediate loads of parasite levels
Definitions are provided in the understanding evolution website glossary, http://evolution.berkeley.edu/evolibrary/glossary/glossary.php (13 October
2016, date last accessed).
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which, while identical in genetic sequence, are dif-
ferent phenotypically due to epigenetic changes (e.g.
DNA methylation), or chance events that occurred
during development and which are passed down
through generations. There are four conditions
required for evolution by natural selection to occur:
variation, heredity, differential reproduction and
time. Level 1 of Bloom’s taxonomy (Table 2) simply
requires a student to remember this definition.
Level 2 (understanding) requires the student to
understand how natural selection works and how
this might impact medicine. Natural selection is
the means by which organisms acquire adaptations
(that is, characteristics that improve an organism’s
differential survival and reproduction) in specific en-
vironments. The student will now need to grasp how
natural selection molds (and in some cases fails to
mold) not just the features of humans but also the
features of the organisms that contribute to their
health and disease. A truly motivated student might
even grasp more complicated concepts, such as how
natural selection plays a role in shaping the life his-
tory features of humans, including senescence—a
fundamental issue in medical practice. In addition,
they would be able to comprehend how positive nat-
ural selection for antibiotic resistance would spread
resistance alleles through pathogen populations
and how positive natural selection would result in
drug resistant cell lineages spreading through
tumors.
At Level 3 (applying) students are expected to be
able to apply procedural knowledge related to nat-
ural selection to a medical issue. For example, they
should be able to calculate the differential reproduct-
ive success of genotypes given sufficient informa-
tion, such as the survival probabilities of the
genotypes and their fecundities. Similarly, if a stu-
dent at Level 3 were given the age-specific survivor-
ship and fecundity of patients with a particular
genetic trait (such as progeria), he or she should
be able to demonstrate that natural selection would
reduce the frequency of such an allele to a very low
level in any population. Another very good example
of applying natural selection to a problem of medical
significance is antimicrobial resistance. Students
should be able to realize that the way in which anti-
microbials are applied to treat a patient’s infection
will have profound impacts on the ability of the mi-
crobe to evolve resistance. For example, will there be
a difference between treating the infection until the
patient feels better (and their own immunity can
handle the infection) or should treatment be
continued for a fixed period with the goal of using
the antimicrobial to completely eradicate the
infection?
Level 4 (analysing) requires the student to analyse
natural selection; such an analysis would lead the
student to the logical implications that natural se-
lection has for the field of medicine. Because this
level is particularly important for medical practice,
we will provide an illustrative example. The first
cases of sickle-cell anemia were described in the lat-
ter portion of the 19th century [18]. Emmel found the
trait in the father of one of the first reported sickle-
cell anemia cases, which suggested a genetic basis
to the disease [19]. By the 1940s, it was realized that
sickle-cell anemia was widespread in tropical-equa-
torial Africa, with the severe form more rare than the
moderate form [20, 21]. This led researchers to con-
clude that sickle-cell anemia was inherited as an
autosomal Mendelian dominant trait [18]. Yet at
the same time, the symptoms of sickle-cell anemia
were quite severe. Doctors observed a very high
death rate among young children with the disease
[19]. With these facts at hand, how was it that phys-
icians arrived at the conclusion that sickle anemia
was caused by an autosomal dominant trait? Clearly,
they did not have the level of understanding of nat-
ural selection that would be needed to analyse the
logical effect of natural selection on a highly deleteri-
ous autosomal dominant trait. If they had been
analysing the situation in light of natural selection,
they would have asked the obvious question: if this
trait is an autosomal dominant, how can it be so
frequent? Natural selection would cause an auto-
somal dominant trait with such drastic effects on
survival to be eliminated from the population rap-
idly. Indeed, the evolutionary theory needed to
understand this situation had already been authored
by Haldane and Fisher [22, 23]. If physicians had
applied such reasoning to this case, they would likely
have recognized that they were, instead, dealing with
a recessive trait and a case of heterozygote advan-
tage. Sickle-cell anemia is now recognized as one of
the best-documented cases of evolution in action in
humans both as heterozygote advantage and an
anti-malarial adaptation [24].
The medical implications of having a false model
of the genetics of sickle-cell anemia (resulting from
the failure to analyse the disease through an evolu-
tionary lens) are important. If the trait is understood
to be dominant, a physician providing genetic coun-
seling to a patient displaying the disease would
claim that, on average, 50% of the patient’s children
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would inherit the disease. On the other hand, if the
trait is understood to be a case of heterozygote ad-
vantage, the patient’s children are only expected to
display the disease condition if the patient’s part-
ner’s family carries the sickle-cell allele.
Another well-documented example of how
analysing the process of natural selection can be
relevant to medical practice involves human genetic
variation. Based on evolutionary concepts such as
natural selection, students should expect that pa-
tients carry medically relevant genetic variants and
that these variants are unlikely to conform to socially
defined concepts of ‘race’. For example, past natural
selection impacts how patients respond to the drugs
used to treat their illnesses. Numerous polymorph-
isms have been discovered that are strongly linked to
the ability of patients to tolerate the antipsychotic
drug olanzapine [25]. In one study, 63 persons of
European ancestry were examined, and the following
loci with polymorphisms associated with negative
response to olanzapine were found: CYP2C9
(17.5% carried the allele with risk of negative re-
sponse), TPMT (6.3% genotypes with risk),
UGTIA1 (50.8% carried the risk allele), MDR1
(22.2% genotype at risk) and 5-HTR2A (66.7%
carried the risk allele) [25]. An important learning
objective for medical students at Level 4 of
Bloom’s taxonomy for natural selection is to be able
to analyse how the sorts of genetic variation that
human populations maintain may have been
influenced by episodes of natural selection (or other
evolutionary processes such as gene flow or genetic
drift) in the past, and how this may relate to medical
interventions today. Furthermore, the student with
this level of understanding of natural selection (and
other mechanisms of evolution) would recognize
that human genetic variation does not match so-
cially defined categories of race or ethnicity but is
influenced by the evolutionary history of individual
human populations. This is because socially defined
races are discordant with both the physical and gen-
etic variation observed in our species. For example,
natural selection that influenced the frequency of
alleles associated with skin color variation, did not
at the same time determine the frequency of alleles
associated with any specific disease predisposition
Table 2. A Bloom’s taxonomy of natural selection
Level Action Example
1 Remembering Students know and can recite the definition of natural selection.
2 Understanding Students understand that positive natural selection increases the frequency of variants that im-
prove reproduction and survivorship in a specific environment, such as in the case of antibi-
otic resistance in bacteria.
3 Applying Students can apply the concept of natural selection to a new situation. For example, after
learning about progeria, students should be able to predict that the expected frequencies of
deleterious variants responsible for the genetic disease will be equivalent to their mutation
rate since persons with progeria rarely reproduce.
4 Analysing Students will be able to analyse how different models of natural selection would account for
observations. For example, a correct model of natural selection can account for the fre-
quency of diseases such as sickle-cell anemia (due to heterozygote superiority) and can ex-
plain the prevalence of alleles that provoke negative drug interactions in some patients but
not others.
5 Evaluating Students can evaluate specific evolutionary hypotheses to determine which ideas may have
traction with regards to improving treatment and overall patient outcomes; e.g. how good is
the evidence supporting the hygiene hypothesis? What does the hypothesis predict? What
observations are not supported? For example, students could evaluate evidence for and
against the hygiene hypothesis.
6. Creating Students can now use evolutionary science to create their own hypotheses relevant to improv-
ing treatment and patient outcomes. Students would be able to formulate evolutionarily in-
formed hypotheses to address the spread of complex illnesses due to globalization or
increases in such diseases due to the introduction of novel substances in the environment
or diet.
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or for height [26]. Thus, while we would expect there
to be alleles of medical relevance that are
differentiated by ancestral geographical factors, we
would not expect there to be drugs with impacts that
are race-specific as has been frequently claimed [27,
28]. This does not mean that there are not differ-
ences in the how individuals or populations respond
to drugs; it simply means that these responses do
not correspond to socially defined notions of race. A
particularly troubling example of this ongoing mis-
conception was revealed by the fact that in a recent
study one-half of the medical students surveyed har-
bored false beliefs concerning biological differences
between socially defined racial groups. In conjunc-
tion with these false beliefs they rated the pain of
‘black’ lower than the pain of ‘white’ patients and
as a result made inappropriate treatment recom-
mendations for the ‘black’ patients [29]. The wide-
spread lack of understanding of this issue amongst
medical practitioners and biomedical research sci-
entists is an ongoing problem that training in evolu-
tionary reasoning is uniquely suited to address
[30].When applied to natural selection, Levels 5
(evaluating) and 6 (creating) of Bloom’s taxonomy
may also be viewed as helpful for medical practi-
tioners and critical for medical researchers. Level 5
means that a student can evaluate specific
hypotheses and research related to the impact of
natural selection upon medicine. The hygiene hy-
pothesis is one example of a current idea from the
field of evolutionary science that has gained some
traction lately in the treatment of allergic and auto-
immune disease [31, 32]. This hypothesis seeks to
explain the recent rise in autoimmune disorders—
e.g. it has been estimated that at present at least
40% of the populations of USA and Europe suffer
from one or more types of allergy and that the preva-
lence of allergies in Western industrialized societies
has doubled in the last 15 years [33, 34]. The hygiene
hypothesis is a specific variant of the ‘novel environ-
ment’ idea. It argues that some of our body systems
evolved to function in the presence of infection by
microorganisms and parasitic worms, to which we
were continuously exposed throughout our evolu-
tionary history. According to the hygiene hypothesis,
in a modern industrialized Western environment
where worm and parasite exposure is infrequent,
these physiological processes malfunction resulting
in the rising prevalence of atopic disorders and auto-
immune diseases [34].Evaluation of the hygiene hy-
pothesis would be improved by addressing
additional questions that are inspired by other
evolutionary concepts. First, what trade-offs are
associated with infection by microorganisms and
parasitic worms? We have some data relevant to
evaluating the downside to parasitic microorganism
and intestinal worm (roundworm and flatworm) in-
fection. In 1914, the Rockefeller Public Service
Commission found that 39% of southern school
children (European-American) were infected with
the roundworm (Necator americanus, called hook-
worm) [35]. Individuals with severe hookworm were
shown to have extreme lassitude (mental and phys-
ical) due to severe anemia. It is not hard to demon-
strate that these infections cause significant
mortality [36]. Therefore, natural selection would se-
lect against N.americanus susceptibility and for re-
sistance to such a parasite.
Although the negative fitness impacts of parasitic
infection are relatively simple to demonstrate, the
more significant task is to demonstrate that low to
intermediate levels of the antigens of specific micro-
organisms and parasitic worms have a beneficial ef-
fect on health. Specifically, the hygiene hypothesis
argues that the differences we see between non-suf-
ferers and those suffering from allergic, atopic and
autoimmune disease are primarily caused by shifts
from our ancestral (agricultural) to modern (indus-
trial) environments. The student with Level 5 under-
standing will know how to determine if the increased
prevalence of these diseases could be due to a ‘mis-
match’ of humans and industrialized environments
with few opportunities for infection by worms—and
if intermediate levels of worm infection offer some
protection from these disorders.
Several lines of evidence are consistent with the
idea that intermediate levels of microorganism and
parasite infection can be beneficial for health. A
meta-analysis of papers concerning helminth infec-
tion and metabolic syndrome found that individuals
with a previous or current helminth were 50% less
likely to have an endpoint metabolic dysfunction
comparted to uninfected individuals [37]. In add-
ition, there is evidence that the human intestinal
microbiomes (here including parasitic worms) influ-
ence who develops allergy, atopy and autoimmune
disease and who does not. For example, one study of
school age children in the tropics found a reduced
risk of atopy due to moderate infections with hel-
minths [38]. Infants who had or were developing
atopic disease where shown to have less diverse
microflora than those without the disease [39, 40].
Furthermore, several studies have shown that chil-
dren in farm environments have less allergic disease
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compared with those raised in urban environments,
including Amish children in northern Indiana [41],
children living in Alpine farm environments [42] and
an Austrian study that showed there was more hay
fever and asthma in children living in city versus
farm environments, where a more diverse
microbiome is likely to be acquired [43]. In addition,
Azad et al. utilized a natural experiment to show that
microbial diversity increased in the guts of children
exposed to pets, which simultaneously resulted in
lower levels of atopy and allergic disease relative to
children with lower levels of diversity in their gut flora
[44], and in another experiment, patients who were
inoculated with eggs from Trichuris suis, a flatworm
that does not cause disease, saw a significant reduc-
tion in Crohn’s disease [45]. The results of this study
are additionally supported by an unmatched case-
control study in South Africa that showed that hel-
minth infection was protective against both Crohn’s
disease and ulcerative colitis [46]. Growing evidence
is confirming the idea that the gut microbiome ap-
pears to be intimately tied to immune response;
hence, when it is dis-regulated we observe allergy,
atopy and autoimmune disease [33, 47].
The identification and evaluation of the sorts of
evidence described earlier, relevant to the hygiene
hypothesis, should be achievable by a student with
Level 5 competence with natural selection. These
data would allow the student to evaluate the utility
of this hypothesis (and its variants: the early im-
mune challenge and the old friends hypothesis). In
addition, the student should be able to evaluate data
challenging the hypothesis. For example, there is
evidence of an inverse relationship between some
infections (such as Hepatitis A) and microbiome
diversity. This result (which supports the import-
ance of microbiome diversity as a protection against
infectious disease) has been reproduced in some
populations but not in others; and in fact, there is
still a great deal of inconsistency in the results of
human intervention studies utilizing pre- and pro-
biotics to alleviate allergy [33, 47].
Finally, Level 6 of Bloom’s taxonomy requires that
students be able to formulate and test their own
hypotheses regarding the impact of natural selection
on medicine. We argue that producing students with
this level of understanding will have great benefit for
biomedical research as well as clinical practice. Level
6 involves students creating new ideas and prod-
ucts. With such understanding, students can sug-
gest new ways of approaching health and disease.
Currently, many of these insights are provided by
evolutionary biologists with an interest in medicine.
However, with more thorough grounding in evolu-
tionary concepts and reasoning skills, the doctors
and medical researchers of tomorrow will be able
to develop new hypotheses for investigation that
are more fully informed by an understanding of med-
ical phenomena. For example, the widespread adop-
tion of evolutionary thinking in medicine is likely to
have a profound influence on how to approach pre-
ventive medicine. Indeed, many evolutionary scien-
tists today are arguing that the main cause of the
dramatic increase in the prevalence of major chronic
diseases (heart disease, cancer and diabetes)
experienced by Western industrial populations is
the mismatch between the environments in which
natural selection acted to mold our current physi-
ology (pre-agricultural) and our current post-indus-
trial existence [48–52]. Due to globalization, the
Western world has been exporting its unhealthy life-
style around the world. Thus, we are now beginning
to see dramatic increases in diseases such as dia-
betes in the Asian-Pacific rim [51]. In addition, it is
likely that evolutionary mismatches are also
contributing to the rapid increase in mental health
disorders we are observing in Western industrialized
societies [52]. Again, an evolutionary perspective
would allow us to predict that we will see increasing
prevalence of mental illness concurrent with the ex-
portation of the Western industrial lifestyle and the
Western agricultural diet to cultures that hitherto
had been less exposed to these mismatches. A sim-
ple, clear and testable evolutionary hypothesis
would be that adopting diets and lifestyles that are
more consistent with our evolutionary history will
lessen the prevalence and severity of such diseases.
Doctors and medical researchers with a strong back-
ground in evolutionary concepts will be able to take
these lines of research in new, more concrete and
likely unanticipated, directions.
CONCLUSION
Clearly, the ramifications of natural selection for
medical practice and research are wide-ranging. To
be prepared to practice medicine in the 21st century,
medical students need to master the concept of nat-
ural selection, as well as other evolutionary concepts
fundamental to medicine (such as those illustrated
in Table 1). The application of Bloom’s taxonomy to
mastering the fundamental evolutionary concept of
natural selection is summarized in Table 2. The im-
portance of this sort of basic evolutionary
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background for medical practice is likely to increase
over time. A case that well-illustrates this point is the
continuing advance of genetic technologies. Next
generation sequencing developments are reducing
cost and increasing speeds at rates in excess of
those predicted by Moore’s Law [53]. This will mean
even greater amounts and sophistication of the gen-
etic data available for individual patients. Yet even
with this increase in genomic information, there are
signs of trouble with regard to the gaps in biomed-
ical researchers’ training [54]. In addition, evolution-
ary medicine is a vibrant and growing field of inquiry.
A June 2014 query on the Entrez Pubmed search en-
gine returned 7025 citations under the term ‘evolu-
tionary medicine’—less than one-half that returned
from the term ‘personalized medicine’ at 15 207; 2
years later those same terms returned 10 354 cit-
ations under the term ‘evolutionary medicine’ and
the term ‘personalized medicine’ had grown to
29 589 citations. This indicated that the difference
between publications focusing in these two areas
has grown over the last 2 years. Despite this differ-
ence in emphasis in the biomedical literature, we
would argue that the relevance of many of evolution-
ary medicine’s tenets such as ‘evolutionary mis-
match’ is actually increasing. This is due to
increasing globalization and the export of the
Western lifestyle around the world, and the rate at
which Western societies are accelerating away from
the conditions under which our species evolved.
These forms of environmental change will bring
about new health challenges that will be best ad-
dressed with an evolutionary perspective. For ex-
ample, the 21st century has seen tremendous
strides in technological development. One of the
newest of these, nanotechnology will widely intro-
duce novel materials (nanoparticles and
nanomaterials) into the biosphere. Nanoparticles
may result from natural processes (such as fires),
be industrial byproducts (such as those produced
in diesel exhaust) or be specifically engineered for
their nanoscale properties. Humans have been
exposed to naturally produced nanoparticles for
some time; however, the last decade has seen a mas-
sive increase in and revolution in the types of engin-
eered nanomaterials [55]. These new, engineered
nanoparticles include particulates that have never
been studied and other particulates that have been
previously only been studied as components of mix-
tures [56]. This drastic growth in the production of
nanomaterials will become an immediate concern
for medical toxicology, since at present little
research is being directed at nanosafety [57].
Evolutionary theory alerts us to the possibility that
these new compounds could be highly toxic to living
organisms. In addition, given that nanoparticles are
already in use as biocides against bacteria, evolu-
tionary theory suggests that there is a strong poten-
tial for the rapid evolution of nanoparticle resistance
and the spread of this throughout the microbiome
[58]. Other industrial processes will have significant
impacts for medicine in the 21st century and have
inherent ties to evolutionary biology. Anthropogenic
climate change is likely to increase the rate at which
novel infectious diseases enter the human popula-
tion. This is because as the climate warms, the vec-
tor organisms that transmit many dangerous
human infections will increase their range [59, 60].
This already is being proposed as a causal factor in
the spread of the Zika virus [61]. In addition, global-
ization has increased the capacity of these organ-
isms to be transported to new habitats [62].
Evolutionary theory can help us understand, analyse
and sometimes even predict or alter the trajectory of
emerging infectious disease.
We argue that the future of medical research and
practice will increasingly require an evolutionary per-
spective to address the new health concerns of the
21st century. These will include chronic disease,
mental health, as well as other issues such as
emerging pathogens. The ability of physicians and
biomedical researchers to link ultimate evolutionary
explanations for disease to their proximate mechan-
isms shall become increasingly important.
Therefore the sooner we revise medical preparation
to integrate evolutionary perspectives, the better
primed we will be to address the medical challenges
of the 21st century.
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